Clinical Trial Update: Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This trial update reports the completion of a Phase 1 study evaluating amifostine in combination with chemotherapy for newly diagnosed acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Drug/Agent Toxicity by Tissue/Organ, Leukemia | Phase 1 | Status: COMPLETED